Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc. > Miami Herald Article

<< Previous

Bullboard Posts

Next >>

Comment by Lysandeon Aug 08, 2020 2:23pm

177 Views

Post# 31383070

RE:RE:RE:Miami Herald Article

@Raddnar, if the Twitter troll you are refering to is me or SoulTsunami, then you oughtta shake your f#ck1ng head. That person has been sharing their DD for 4 or 5 months now on ALL stock forums FOR THE BENEFIT OF ALL. They only went to Twitter once they realized just how important Ifenprodil is. READ HIS TWEETS.... I have been following Soul for a long while now and have come to realize the same thing. WE F#CKING NEED IFENPRODIL. AND I WILL CONTINUE TO SPAM MY 5H1T UNTIL SOMEONE F#CKING LISTENS.

#WAR ON FCUKING COVID19

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1